• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Benzenoids Anthracenes Anthraquinones
• Anthraquinones

Recent Advances in the Study of 2,7-Dimethylanthraquinone (CAS: 3286-01-9) in Chemical Biology and Pharmaceutical Research

2,7-Dimethylanthraquinone (CAS: 3286-01-9) is a synthetic anthraquinone derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. Anthraquinones are a class of naturally occurring and synthetic compounds known for their diverse biological activities, including anticancer, antimicrobial, and anti-inflammatory properties. The dimethyl substitution at the 2 and 7 positions of the anthraquinone scaffold imparts unique chemical and biological properties to this compound, making it a promising candidate for further investigation.

Recent studies have focused on elucidating the molecular mechanisms underlying the biological activities of 2,7-Dimethylanthraquinone. One key area of interest is its potential as an anticancer agent. In vitro studies have demonstrated that this compound exhibits selective cytotoxicity against various cancer cell lines, including breast, lung, and colon cancers. The compound's ability to induce apoptosis and inhibit cell proliferation has been attributed to its interaction with cellular targets such as DNA topoisomerases and reactive oxygen species (ROS) generation pathways. These findings suggest that 2,7-Dimethylanthraquinone could serve as a lead compound for the development of novel anticancer therapies.

Another promising avenue of research involves the antimicrobial properties of 2,7-Dimethylanthraquinone. Recent investigations have revealed its efficacy against a range of pathogenic bacteria and fungi, including multidrug-resistant strains. The compound's mechanism of action appears to involve disruption of microbial cell membranes and interference with essential metabolic pathways. These properties make it a potential candidate for the development of new antimicrobial agents, particularly in the face of rising antibiotic resistance.

In addition to its direct biological activities, 2,7-Dimethylanthraquinone has also been explored as a building block for the synthesis of more complex pharmaceutical compounds. Its chemical structure allows for various modifications, enabling the creation of derivatives with enhanced potency or reduced toxicity. Recent synthetic efforts have focused on optimizing these modifications to improve the compound's pharmacokinetic and pharmacodynamic profiles.

The safety profile of 2,7-Dimethylanthraquinone has also been a subject of recent investigation. While the compound shows promising biological activities, researchers are carefully evaluating its potential toxicity and side effects. Preliminary studies suggest that the compound may have a favorable therapeutic index, but further in vivo studies are needed to fully assess its safety for potential clinical applications.

Looking forward, research on 2,7-Dimethylanthraquinone is expected to expand into several directions. These include more detailed mechanistic studies to identify specific molecular targets, optimization of its chemical structure for improved efficacy and safety, and exploration of its potential in combination therapies. The compound's unique properties position it as a valuable tool for both basic research and drug development in the chemical biology and pharmaceutical fields.

In conclusion, 2,7-Dimethylanthraquinone (CAS: 3286-01-9) represents an exciting area of research in chemical biology and pharmaceutical science. Its diverse biological activities, coupled with its potential for structural modification, make it a promising candidate for the development of new therapeutic agents. As research continues to uncover its mechanisms of action and optimize its properties, this compound may play an increasingly important role in addressing various medical challenges.

• 954-16-5(2,4,6-Trimethylbenzophenone)
• 89-74-7(2',4'-Dimethylacetophenone)
• 1090-13-7(5,12-Napthacenequinone)
• 82-05-3(1,9-Benz-10-anthrone)
• 84-65-1(Anthraquinone)
• 577-16-2(2'-Methylacetophenone)
• 84-47-9(2-Tert-Butylanthraquinone)
• 84-51-5(2-Ethylanthraquinone)
• 131-58-8(2-Methylbenzophenone)
• 2498-66-0(Benzaanthracene-7,12-dione)